Amedisys PE Ratio 2010-2025 | AMED
Current and historical p/e ratio for Amedisys (AMED) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Amedisys PE ratio as of May 07, 2025 is 21.22.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Amedisys PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2025-05-07 |
96.14 |
|
35.48 |
| 2025-03-31 |
92.63 |
$2.71 |
34.18 |
| 2024-12-31 |
90.79 |
$1.31 |
69.31 |
| 2024-09-30 |
96.51 |
$2.52 |
38.30 |
| 2024-06-30 |
91.80 |
$2.80 |
32.79 |
| 2024-03-31 |
92.16 |
$-0.64 |
0.00 |
| 2023-12-31 |
95.06 |
$-0.31 |
0.00 |
| 2023-09-30 |
93.40 |
$0.07 |
1334.29 |
| 2023-06-30 |
91.44 |
$0.07 |
1306.29 |
| 2023-03-31 |
73.55 |
$3.44 |
21.38 |
| 2022-12-31 |
83.54 |
$3.64 |
22.95 |
| 2022-09-30 |
96.79 |
$3.71 |
26.09 |
| 2022-06-30 |
105.12 |
$4.29 |
24.50 |
| 2022-03-31 |
172.29 |
$5.81 |
29.65 |
| 2021-12-31 |
161.88 |
$6.34 |
25.53 |
| 2021-09-30 |
149.10 |
$6.66 |
22.39 |
| 2021-06-30 |
244.93 |
$7.45 |
32.88 |
| 2021-03-31 |
264.79 |
$6.06 |
43.69 |
| 2020-12-31 |
293.33 |
$5.52 |
53.14 |
| 2020-09-30 |
236.43 |
$4.99 |
47.38 |
| 2020-06-30 |
198.54 |
$3.86 |
51.44 |
| 2020-03-31 |
183.54 |
$3.84 |
47.80 |
| 2019-12-31 |
166.92 |
$3.83 |
43.58 |
| 2019-09-30 |
131.01 |
$3.84 |
34.12 |
| 2019-06-30 |
121.41 |
$3.77 |
32.20 |
| 2019-03-31 |
123.26 |
$3.73 |
33.05 |
| 2018-12-31 |
117.11 |
$3.57 |
32.80 |
| 2018-09-30 |
124.96 |
$2.62 |
47.69 |
| 2018-06-30 |
85.46 |
$2.08 |
41.09 |
| 2018-03-31 |
60.34 |
$1.23 |
49.06 |
| 2017-12-31 |
52.71 |
$0.88 |
59.90 |
| 2017-09-30 |
55.96 |
$1.25 |
44.77 |
| 2017-06-30 |
62.81 |
$1.17 |
53.68 |
| 2017-03-31 |
51.09 |
$1.36 |
37.57 |
| 2016-12-31 |
42.63 |
$1.11 |
38.41 |
| 2016-09-30 |
47.44 |
$1.23 |
38.57 |
| 2016-06-30 |
50.48 |
$1.14 |
44.28 |
| 2016-03-31 |
48.34 |
$1.14 |
42.40 |
| 2015-12-31 |
39.32 |
$-0.12 |
0.00 |
| 2015-09-30 |
37.97 |
$-0.22 |
0.00 |
| 2015-06-30 |
39.73 |
$-0.21 |
0.00 |
| 2015-03-31 |
26.78 |
$-0.30 |
0.00 |
| 2014-12-31 |
29.35 |
$0.38 |
77.24 |
| 2014-09-30 |
20.17 |
$-0.20 |
0.00 |
| 2014-06-30 |
16.74 |
$-3.35 |
0.00 |
| 2014-03-31 |
14.89 |
$-3.52 |
0.00 |
| 2013-12-31 |
14.63 |
$-3.04 |
0.00 |
| 2013-09-30 |
17.21 |
$-6.26 |
0.00 |
| 2013-06-30 |
11.60 |
$-3.04 |
0.00 |
| 2013-03-31 |
11.12 |
$-2.84 |
0.00 |
| 2012-12-31 |
11.31 |
$-2.75 |
0.00 |
| 2012-09-30 |
13.82 |
$0.92 |
15.02 |
| 2012-06-30 |
12.45 |
$-14.14 |
0.00 |
| 2012-03-31 |
14.46 |
$-13.65 |
0.00 |
| 2011-12-31 |
10.91 |
$-13.30 |
0.00 |
| 2011-09-30 |
14.82 |
$-12.68 |
0.00 |
| 2011-06-30 |
26.63 |
$2.81 |
9.48 |
| 2011-03-31 |
35.00 |
$3.19 |
10.97 |
| 2010-12-31 |
33.50 |
$3.95 |
8.48 |
| 2010-09-30 |
23.80 |
$4.53 |
5.25 |
| 2010-06-30 |
43.98 |
$5.06 |
8.69 |
| 2010-03-31 |
55.22 |
$5.20 |
10.62 |
| 2009-12-31 |
48.60 |
$4.90 |
9.92 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$3.154B |
$2.348B |
|
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
|
